Zhiwei Song PhD

Dr. Zhiwei Song obtained his Ph.D. degree in Biochemistry from the University of Michigan where he studied plant lectins and protein glycosylation in cancer cells. His post-doc work was completed in the Biology Department at MIT where he studied the genetic control of apoptosis. In 2002, Dr. Song moved to Singapore. Now he is a Principal Scientist at the Bioprocessing Technology Institute (BTI) of A*STAR. His research has been focused on protein glycosylation, glycoengineering of CHO cells, production of recombinant antibodies using CHO cells and apoptotic cell death in cultured mammalian cells.